海南省缺血性脑卒中二级预防中抗血小板药物治疗的现状及影响因素分析

Antiplatelet drug therapy for secondary prevention of cerebral ischemic stroke and its influence factors in Hainan Province

目的调查分析缺血性脑卒中二级预防中抗血小板药物的使用现状及影响因素。方法入选海南省10家综合性医院再次住院的缺血性脑卒中患者1300例,调查患者入院时抗血小板药物的应用状况,采用单因素及多因素logistic回归模型对资料进行分析。结果缺血性脑卒中患者抗血小板治疗知晓率为60.4%,治疗率为49.2%。多因素logistic回归分析显示,教育程度、医疗保险、健康教育是患者服用抗血小板治疗的独立危险因素。结论缺血性脑卒中二级预防中抗血小板治疗现状令人堪忧,临床医师需提高认识,加强对脑卒中患者的健康教育,建议患者长期服药,提高脑卒中后抗血小板治疗的知晓率及治疗率。

Objective To investigate the antiplatelet drug therapy for secondary prevention of cerebral ischemic stroke and its influence factors. Methods A total of 1300 cerebral ischemic stroke patients readmitted to 10 general hospitals in Hainan Province were included in this study. Drugs used in their antiplatelet therapy were investigated and analyzed by univariate and multivariate logistic regression analysis. Results The aware rate and curative rate of antiplatelet therapy were 60.4% and 49.2%, respectively,in the patients. Multivariate logistic regression analysis showed that education level, medical insurance and health education were the independent factors for antiplatelet therapy for the secondary prevention of cerebral ischemic stroke. Conclusion Antiplatelet therapy for the secondary prevention of cerebral ischemic stroke is not optimistic. Clinicians need to improve their understanding of cerebral ischemic stroke and strengthen their health education in order to improve their aware and curative rate of antiplatelet therapy.